Back to FDA Applications sponsored by US PHARM HOLDINGS

FDA Drug Application 020623 by US PHARM HOLDINGS

Application Number020623
Application Type New Drug Application
Sponsor ApplicantUS PHARM HOLDINGS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP09/11/1997N24942000 3/3/2010
AP06/1/2005SLR11747004 6/7/2005
AP06/1/2005SLR11770004 6/7/2005
AP05/30/2007SLR16677006,020624s016ltr.pdf 6/4/2007
AP05/30/2007SLR16697006,020624s016lbl.pdf 6/4/2007
AP09/24/2007SLR18049007, 020624s017ltr.pdf 9/26/2007
AP010/6/2009SLR23569008 10/14/2009
AP010/6/2009SLR23807008 11/10/2009
AP09/22/2011SLR30084009 9/27/2011
AP09/22/2011SLR30099009 9/28/2011
AP09/16/2013SLR37100010,020624s023lbl.pdf 9/16/2013
AP09/16/2013SLR37105010,020624Orig1s023ltr.pdf 9/17/2013
AP09/18/2014SLR40540012 9/22/2014
AP09/18/2014SLR40553012 9/23/2014

Back to FDA Applications sponsored by US PHARM HOLDINGS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.